SAN DIEGO, March 10, 2025 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, announced today that ...

Aerospace and defense company Kratos (NASDAQ:KTOS) will be reporting results tomorrow afternoon. Here’s what to expect. Kratos met analysts’ revenue expectations last quarter, reporting ...

God of War's Kratos has had a busy life: he's birthed a teenager, slain the gods, and grown the kind of luscious beard that would make a lumberjack fume - all that and he's only 20 years old!

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in the defense, national security and global markets, announced today ...

Kratos remains the most overvalued company in the sector with a P/E (TTM) of 272x, even after the recent 20% drop in the share price. One of the lowest margin companies in the sector cannot be ...

As Alcon Research seeks to block investee Aurion Biotech from listing on the New York Stock Exchange, another investor has come to Aurion’s defense. Deerfield Management has sued Alcon Research ...

According to the TOS, MMFA alleged, X requires any litigation over use of its services to be "brought solely in the federal or state courts located in San Francisco County, California, United States." ...

Players can access dark-themed skins, armor, weapons, and shield appearances for Kratos, Atreus, and Freya. The update includes the ability to edit appearance for Kratos' arsenal, allowing ...

Kratos Defense & Security Solutions, Inc. KTOS is set to release fourth-quarter 2024 results on Feb. 26, after market close. See the Zacks Earnings Calendar to stay ahead of market-making news ...

Disclaimer: Glass's Information Services (GIS) and CarsGuide Autotrader Media Solutions Pty Ltd. (CarsGuide) provide this information based on data from a range of sources including third parties.

Alcon Research LLC is trying to engineer a cheap acquisition of Aurion Biotech Inc. by blocking Aurion’s other funding options and improperly gaining influence on its board, Aurion investors claim in ...